Price (delayed)
$1.165
Market cap
$59.95M
P/E Ratio
1.27
Dividend/share
N/A
EPS
$0.92
Enterprise value
$10.05M
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous
There are no recent dividends present for ENZ.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.